Israel Anti-Hypertensive Drugs Market is Expected to be Dominated by Therapeutic Class Type Through 2028
Rising incidence of hypertension across the country is
expected to drive the growth of the market in the forecast period 2024 – 2028.
According to TechSci
Research report, “Israel
Anti-Hypertensive Drugs - By Region, Forecast and Opportunities, 2018-2028”, the Israel Anti-Hypertensive Drugs Market is expected to grow with an
impressive CAGR during the forecast period 2024 - 2028. The rise in prevalence
of stress, hypertension, acquisitions, expansions, and strategic collaborations,
and recent developments are boosting the growth of Israel Anti-Hypertensive
Drugs Market. The growing awareness amongst the key market players including
manufacturers who are involved in new drug production with high efficacy, shows
the growth of Israel Anti-Hypertensive Drugs Market.
However, one of the main
contributing factors to the increasing prevalence of hypertension is the aging
population. As people age, the risk of developing hypertension increases. In
addition, unhealthy lifestyles, such as a diet high in salt and saturated fat,
sedentary behavior, and smoking, are also major risk factors for hypertension which enhanced the growth
of the market in the forecast period. Also, the ongoing advancements in medical
research and clinical studies contribute to the development of new and improved
anti-hypertensive drugs. The introduction of innovative medications with
enhanced efficacy, fewer side effects, and better patient compliance can drive
the growth of Israel Anti-Hypertensive Drugs Market.
Additionally, another
important factor contributing to the increasing prevalence of hypertension is
stress. Though stress can cause a temporary increase in blood pressure, chronic
stress can lead to long-term hypertension.
Browse over XX market
data Figures spread through XX Pages and an in-depth TOC on "Israel Anti-Hypertensive Drugs Market"
The Israel
Anti-Hypertensive Drugs Market can be segmented by therapeutic
class, type, distribution channel and region.
Based on therapeutic
class, the market can be bifurcated into Diuretics, ACE inhibitors, Angiotensin
Receptor Blockers (ARBs), Calcium Channel Blockers, Beta Adrenergic Blockers,
Renin Inhibitors, Vasodilators, and Others. The calcium channel blockers segment
occupied the largest antihypertensive drugs market share in 2018, due to lesser
side effects. However, the ACE inhibitors segment is anticipated to depict the fastest
growth during the forecast period.
In terms of type,
the market can be split into Primary Hypertension and Secondary Hypertension. The
Primary Hypertension segment occupied the largest antihypertensive drugs market
share in 2018, due to requirement of appropriate blood pressure on regular
basis. However, the secondary hypertension segment is anticipated to depict
fastest growth during the forecast period.
Based on the distribution
channel, the market can be classified into following categories, Retail
Pharmacy, Hospital Pharmacy, E-commerce Websites & Online Drug Stores. The hospitals
pharmacy segment is expected to show an impressive growth in forecast period
due to ease and availability of the drugs.
Major
companies operating in Israel Anti-Hypertensive Drugs Market include:
- Pfizer Pharmaceuticals Israel
Ltd
- MERCK SERONO LTD.
- AstraZeneca Israel Inc
- Novartis Pharma Israel Ltd
- Sanofi-Aventis Israel Ltd
- Boehringer Ingelheim Israel
Ltd.
- Bristol-Myers Squibb Israel
Ltd.
- Takeda Israel Inc.
- Teva Israel Ltd.
- Servier Israel Inc.
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
“Israel Anti-Hypertensive Drugs Market is expected to witness
significant growth during the forecast period on account of increasing number
of hypertensive patients. An increase in awareness of the health risks
associated with hypertension supports the demand for Anti-Hypertensive Drugs
Market in Israel. Additionally, increase in emergence of players developing new
drugs to prevent from heart failure and heart stroke, is expected to create
lucrative opportunities for the market growth in the next few years”
said Mr. Karan Chechi, Research Director with TechSci Research, a research-based
global management consulting firm.
“Israel
Anti-Hypertensive Drugs Market, By Therapeutic Class (Diuretics, ACE
inhibitors, Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers,
Beta Adrenergic Blockers, Renin Inhibitors, Vasodilators, Others), By Type
(Primary Hypertension, Secondary Hypertension), By Distribution Channel (Retail
Pharmacy, Hospital Pharmacy, E-commerce Websites & Online Drug Stores), By
Region, Competition Forecast & Opportunities, 2028F”, has evaluated the future
growth potential of Israel Anti-Hypertensive Drugs Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Israel Anti-Hypertensive Drugs Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com